BRIEF-Alzecure Pharma Enters Into Collaboration, Out-Licensing Agreement With Lilly For Alzheimer’s Project

Eli Lilly and Company

Eli Lilly and Company

LLY

0.00

June 9 (Reuters) - AlzeCure Pharma AB ALZCUR.ST:

  • ENTERS INTO A COLLABORATION AND OUT-LICENSING AGREEMENT WITH LILLY FOR ALZHEIMER’S PROJECT

  • DEAL VALUE MAY EXCEED $1 BILLION EXCLUDING ROYALTIES; $10 MILLION UPFRONT PAYMENT TO ALZECURE

  • DEAL SUBJECT TO SWEDISH AUTHORITY APPROVAL UNDER FOREIGN DIRECT INVESTMENT REGULATIONS

Source text: ID:nMFN5pzQ2t

Further company coverage: ALZCUR.ST


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.